Skip to main content

Advertisement

Log in

No alteration of voriconazole concentration by plasmapheresis in a critically ill patient

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Bassetti M, Righi E, De Pascale G, De Gaudio R, Giarratano A, Mazzei T, Morace G, Petrosillo N, Stefani S, Antonelli M (2014) How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care 18(4):458. https://doi.org/10.1186/s13054-014-0458-4

    Article  PubMed  PubMed Central  Google Scholar 

  2. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63(4):e1–e60. https://doi.org/10.1093/cid/ciw326

    Article  PubMed  PubMed Central  Google Scholar 

  3. Theuretzbacher U, Ihle F, Derendorf H (2006) Pharmacokinetic/pharmacodynamic profile of voriconazole. Clin Pharmacokinet 45(7):649–663. https://doi.org/10.2165/00003088-200645070-00002

    Article  CAS  PubMed  Google Scholar 

  4. Pascual A, Csajka C, Buclin T, Bolay S, Bille J, Calandra T, Marchetti O (2012) Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Clin Infect Dis 55(3):381–390. https://doi.org/10.1093/cid/cis437

    Article  CAS  PubMed  Google Scholar 

  5. Ibrahim RB, Liu C, Cronin SM, Murphy BC, Cha R, Swerdlow P, Edwards DJ (2007) Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy 27(11):1529–1549. https://doi.org/10.1592/phco.27.11.1529

    Article  CAS  PubMed  Google Scholar 

  6. Kintzel PE, Eastlund T, Calis KA (2003) Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apher 18(4):194–205. https://doi.org/10.1002/jca.10074

    Article  PubMed  Google Scholar 

  7. Spriet I, Bruggemann RJ, Annaert P, Meersseman P, Van Wijngaerden E, Lagrou K, Willems L (2013) Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange. Ther Drug Monit 35(1):141–143. https://doi.org/10.1097/FTD.0b013e31827d76b0

    Article  CAS  PubMed  Google Scholar 

  8. Pfizer Vfend: Summary of product characteristics. state of information: January 2017 https://www.fachinfo.de/pdf/015292 (accessed 08/2018)

  9. Vanstraelen K, Wauters J, De Loor H, Vercammen I, Annaert P, Lagrou K, Spriet I (2014) Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis. J Pharm Sci 103(8):2565–2570. https://doi.org/10.1002/jps.24064

    Article  CAS  PubMed  Google Scholar 

  10. Preston C Stockley’s drug interactions [online]. In: ed Pharmaceutical Press www.medicinescomplete.com (accessed 08/2018)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerd Mikus.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent of the patient

Informed consent of the patient was obtained.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vay, M., Foerster, K.I., Mahmoudi, M. et al. No alteration of voriconazole concentration by plasmapheresis in a critically ill patient. Eur J Clin Pharmacol 75, 287–288 (2019). https://doi.org/10.1007/s00228-018-2582-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-2582-6

Navigation